APO Research
Talk to an analyst

APO RESEARCH · REPORT

Selpercatinib Capsules

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Selpercatinib Capsules Market Analysis and Forecast 2026-2032

27 December 2025191 pages

Choose your research edition.

Industry ResearchSelpercatinib Capsules Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Selpercatinib Capsules Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Selpercatinib Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Selpercatinib Capsules Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Selpercatinib Capsules Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Selpercatinib Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Selpercatinib Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Selpercatinib Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Selpercatinib Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Selpercatinib Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Selpercatinib Capsules include Innovnent Biologics and Eli Lilly etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Selpercatinib Capsules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Selpercatinib Capsules, also provides the sales of main regions and countries. Of the upcoming market potential for Selpercatinib Capsules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Selpercatinib Capsules sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Selpercatinib Capsules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Selpercatinib Capsules sales, projected growth trends, production technology, application and end-user industry.

Selpercatinib Capsules Segment by Company

Innovnent Biologics

Eli Lilly

Selpercatinib Capsules Segment by Type

40mg

80mg

Selpercatinib Capsules Segment by Application

Thyroid Carcinoma

Non-Small Cell Lung Cancer (NSCLC)

Others

Selpercatinib Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Selpercatinib Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Selpercatinib Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Selpercatinib Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Selpercatinib Capsules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Selpercatinib Capsules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Selpercatinib Capsules sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Selpercatinib Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 40mg Major Manufacturers Table 3. 80mg Major Manufacturers Table 4. Global Selpercatinib Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Thyroid Carcinoma Major Manufacturers Table 6. Non-Small Cell Lung Cancer (NSCLC) Major Manufacturers Table 7. Others Major Manufacturers Table 8. Selpercatinib Capsules Industry Trends Table 9. Selpercatinib Capsules Industry Drivers Table 10. Selpercatinib Capsules Industry Opportunities and Challenges Table 11. Selpercatinib Capsules Industry Restraints Table 12. Global Selpercatinib Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Selpercatinib Capsules Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Selpercatinib Capsules Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Selpercatinib Capsules Revenue Market Share by Region (2021-2026) Table 16. Global Selpercatinib Capsules Revenue Market Share by Region (2027-2032) Table 17. Global Selpercatinib Capsules Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Selpercatinib Capsules Sales by Region (2021-2026) & (K Units) Table 19. Global Selpercatinib Capsules Sales by Region (2027-2032) & (K Units) Table 20. Global Selpercatinib Capsules Sales Market Share by Region (2021-2026) Table 21. Global Selpercatinib Capsules Sales Market Share by Region (2027-2032) Table 22. Global Selpercatinib Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Selpercatinib Capsules Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Selpercatinib Capsules Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Selpercatinib Capsules Sales Market Share by Manufacturers (2021-2026) Table 26. Global Selpercatinib Capsules Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Selpercatinib Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Selpercatinib Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Selpercatinib Capsules Manufacturers, Product Type & Application Table 30. Global Selpercatinib Capsules Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Selpercatinib Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Selpercatinib Capsules Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Selpercatinib Capsules Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Selpercatinib Capsules Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Selpercatinib Capsules Revenue Market Share by Type (2021-2026) Table 37. Global Selpercatinib Capsules Revenue Market Share by Type (2027-2032) Table 38. Global Selpercatinib Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Selpercatinib Capsules Sales by Type (2021-2026) & (K Units) Table 40. Global Selpercatinib Capsules Sales by Type (2027-2032) & (K Units) Table 41. Global Selpercatinib Capsules Sales Market Share by Type (2021-2026) Table 42. Global Selpercatinib Capsules Sales Market Share by Type (2027-2032) Table 43. Global Selpercatinib Capsules Price by Type (2021-2026) & (US$/Unit) Table 44. Global Selpercatinib Capsules Price by Type (2027-2032) & (US$/Unit) Table 45. Global Selpercatinib Capsules Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Selpercatinib Capsules Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Selpercatinib Capsules Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Selpercatinib Capsules Revenue Market Share by Application (2021-2026) Table 49. Global Selpercatinib Capsules Revenue Market Share by Application (2027-2032) Table 50. Global Selpercatinib Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Selpercatinib Capsules Sales by Application (2021-2026) & (K Units) Table 52. Global Selpercatinib Capsules Sales by Application (2027-2032) & (K Units) Table 53. Global Selpercatinib Capsules Sales Market Share by Application (2021-2026) Table 54. Global Selpercatinib Capsules Sales Market Share by Application (2027-2032) Table 55. Global Selpercatinib Capsules Price by Application (2021-2026) & (US$/Unit) Table 56. Global Selpercatinib Capsules Price by Application (2027-2032) & (US$/Unit) Table 57. Innovnent Biologics Company Information Table 58. Innovnent Biologics Business Overview Table 59. Innovnent Biologics Selpercatinib Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Innovnent Biologics Selpercatinib Capsules Product Portfolio Table 61. Innovnent Biologics Recent Development Table 62. Eli Lilly Company Information Table 63. Eli Lilly Business Overview Table 64. Eli Lilly Selpercatinib Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Eli Lilly Selpercatinib Capsules Product Portfolio Table 66. Eli Lilly Recent Development Table 67. North America Selpercatinib Capsules Revenue by Type (2021-2026) & (US$ Million) Table 68. North America Selpercatinib Capsules Revenue by Type (2027-2032) & (US$ Million) Table 69. North America Selpercatinib Capsules Sales by Type (2021-2026) & (K Units) Table 70. North America Selpercatinib Capsules Sales by Type (2027-2032) & (K Units) Table 71. North America Selpercatinib Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 72. North America Selpercatinib Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 73. North America Selpercatinib Capsules Revenue by Application (2021-2026) & (US$ Million) Table 74. North America Selpercatinib Capsules Revenue by Application (2027-2032) & (US$ Million) Table 75. North America Selpercatinib Capsules Sales by Application (2021-2026) & (K Units) Table 76. North America Selpercatinib Capsules Sales by Application (2027-2032) & (K Units) Table 77. North America Selpercatinib Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 78. North America Selpercatinib Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 79. North America Selpercatinib Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Selpercatinib Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 81. North America Selpercatinib Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 82. North America Selpercatinib Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 83. North America Selpercatinib Capsules Sales by Country (2021-2026) & (K Units) Table 84. North America Selpercatinib Capsules Sales by Country (2027-2032) & (K Units) Table 85. North America Selpercatinib Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 86. North America Selpercatinib Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 87. United States Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 88. Canada Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 89. Mexico Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 90. Europe Selpercatinib Capsules Revenue by Type (2021-2026) & (US$ Million) Table 91. Europe Selpercatinib Capsules Revenue by Type (2027-2032) & (US$ Million) Table 92. Europe Selpercatinib Capsules Sales by Type (2021-2026) & (K Units) Table 93. Europe Selpercatinib Capsules Sales by Type (2027-2032) & (K Units) Table 94. Europe Selpercatinib Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 95. Europe Selpercatinib Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 96. Europe Selpercatinib Capsules Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Selpercatinib Capsules Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Selpercatinib Capsules Sales by Application (2021-2026) & (K Units) Table 99. Europe Selpercatinib Capsules Sales by Application (2027-2032) & (K Units) Table 100. Europe Selpercatinib Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 101. Europe Selpercatinib Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 102. Europe Selpercatinib Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Selpercatinib Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. Europe Selpercatinib Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. Europe Selpercatinib Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 106. Europe Selpercatinib Capsules Sales by Country (2021-2026) & (K Units) Table 107. Europe Selpercatinib Capsules Sales by Country (2027-2032) & (K Units) Table 108. Europe Selpercatinib Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 109. Europe Selpercatinib Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 110. Germany Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 111. France Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 112. U.K. Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 113. Italy Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 114. Russia Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 115. Spain Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 116. Netherlands Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 117. Switzerland Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 118. Sweden Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 119. Poland Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 120. China Selpercatinib Capsules Revenue by Type (2021-2026) & (US$ Million) Table 121. China Selpercatinib Capsules Revenue by Type (2027-2032) & (US$ Million) Table 122. China Selpercatinib Capsules Sales by Type (2021-2026) & (K Units) Table 123. China Selpercatinib Capsules Sales by Type (2027-2032) & (K Units) Table 124. China Selpercatinib Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 125. China Selpercatinib Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 126. China Selpercatinib Capsules Revenue by Application (2021-2026) & (US$ Million) Table 127. China Selpercatinib Capsules Revenue by Application (2027-2032) & (US$ Million) Table 128. China Selpercatinib Capsules Sales by Application (2021-2026) & (K Units) Table 129. China Selpercatinib Capsules Sales by Application (2027-2032) & (K Units) Table 130. China Selpercatinib Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 131. China Selpercatinib Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Asia Selpercatinib Capsules Revenue by Type (2021-2026) & (US$ Million) Table 133. Asia Selpercatinib Capsules Revenue by Type (2027-2032) & (US$ Million) Table 134. Asia Selpercatinib Capsules Sales by Type (2021-2026) & (K Units) Table 135. Asia Selpercatinib Capsules Sales by Type (2027-2032) & (K Units) Table 136. Asia Selpercatinib Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 137. Asia Selpercatinib Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 138. Asia Selpercatinib Capsules Revenue by Application (2021-2026) & (US$ Million) Table 139. Asia Selpercatinib Capsules Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Selpercatinib Capsules Sales by Application (2021-2026) & (K Units) Table 141. Asia Selpercatinib Capsules Sales by Application (2027-2032) & (K Units) Table 142. Asia Selpercatinib Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 143. Asia Selpercatinib Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 144. Asia Selpercatinib Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Selpercatinib Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Asia Selpercatinib Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Asia Selpercatinib Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 148. Asia Selpercatinib Capsules Sales by Country (2021-2026) & (K Units) Table 149. Asia Selpercatinib Capsules Sales by Country (2027-2032) & (K Units) Table 150. Asia Selpercatinib Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 151. Asia Selpercatinib Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 152. Japan Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 153. South Korea Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 154. India Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 155. Australia Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 156. Taiwan Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 157. Southeast Asia Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 158. SAMEA Selpercatinib Capsules Revenue by Type (2021-2026) & (US$ Million) Table 159. SAMEA Selpercatinib Capsules Revenue by Type (2027-2032) & (US$ Million) Table 160. SAMEA Selpercatinib Capsules Sales by Type (2021-2026) & (K Units) Table 161. SAMEA Selpercatinib Capsules Sales by Type (2027-2032) & (K Units) Table 162. SAMEA Selpercatinib Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 163. SAMEA Selpercatinib Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 164. SAMEA Selpercatinib Capsules Revenue by Application (2021-2026) & (US$ Million) Table 165. SAMEA Selpercatinib Capsules Revenue by Application (2027-2032) & (US$ Million) Table 166. SAMEA Selpercatinib Capsules Sales by Application (2021-2026) & (K Units) Table 167. SAMEA Selpercatinib Capsules Sales by Application (2027-2032) & (K Units) Table 168. SAMEA Selpercatinib Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 169. SAMEA Selpercatinib Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 170. SAMEA Selpercatinib Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. SAMEA Selpercatinib Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. SAMEA Selpercatinib Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. SAMEA Selpercatinib Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. SAMEA Selpercatinib Capsules Sales by Country (2021-2026) & (K Units) Table 175. SAMEA Selpercatinib Capsules Sales by Country (2027-2032) & (K Units) Table 176. SAMEA Selpercatinib Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 177. SAMEA Selpercatinib Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 178. Brazil Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 179. Argentina Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 180. Chile Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 181. Colombia Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 182. Peru Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 183. Saudi Arabia Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 184. Israel Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 185. UAE Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 186. Turkey Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 187. Iran Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 188. Egypt Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Selpercatinib Capsules Distributors List Table 192. Selpercatinib Capsules Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Selpercatinib Capsules Image Figure 2. Global Selpercatinib Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Selpercatinib Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 4. 40mg Image Figure 5. 80mg Image Figure 6. Global Selpercatinib Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Selpercatinib Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 8. Thyroid Carcinoma Image Figure 9. Non-Small Cell Lung Cancer (NSCLC) Image Figure 10. Others Image Figure 11. Global Selpercatinib Capsules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Selpercatinib Capsules Revenue (2021-2032) & (US$ Million) Figure 13. Global Selpercatinib Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Selpercatinib Capsules Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Selpercatinib Capsules Revenue Market Share by Region (2021-2032) Figure 16. Global Selpercatinib Capsules Sales (2021-2032) & (K Units) Figure 17. Global Selpercatinib Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Selpercatinib Capsules Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Selpercatinib Capsules Sales YoY (2021-2032) & (K Units) Figure 20. Europe Selpercatinib Capsules Sales YoY (2021-2032) & (K Units) Figure 21. China Selpercatinib Capsules Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Selpercatinib Capsules Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Selpercatinib Capsules Sales YoY (2021-2032) & (K Units) Figure 24. Global Selpercatinib Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Selpercatinib Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Selpercatinib Capsules Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Selpercatinib Capsules Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Selpercatinib Capsules Revenue Market Share by Type (2021-2032) Figure 30. Global Selpercatinib Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Selpercatinib Capsules Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Selpercatinib Capsules Sales Market Share by Type (2021-2032) Figure 33. Global Selpercatinib Capsules Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Selpercatinib Capsules Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Selpercatinib Capsules Revenue Market Share by Application (2021-2032) Figure 36. Global Selpercatinib Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Selpercatinib Capsules Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Selpercatinib Capsules Sales Market Share by Application (2021-2032) Figure 39. North America Selpercatinib Capsules Revenue Share by Type (2021-2032) Figure 40. North America Selpercatinib Capsules Sales Share by Type (2021-2032) Figure 41. North America Selpercatinib Capsules Revenue Share by Application (2021-2032) Figure 42. North America Selpercatinib Capsules Sales Share by Application (2021-2032) Figure 43. North America Selpercatinib Capsules Revenue Share by Country (2021-2032) Figure 44. North America Selpercatinib Capsules Sales Share by Country (2021-2032) Figure 45. Europe Selpercatinib Capsules Revenue Share by Type (2021-2032) Figure 46. Europe Selpercatinib Capsules Sales Share by Type (2021-2032) Figure 47. Europe Selpercatinib Capsules Revenue Share by Application (2021-2032) Figure 48. Europe Selpercatinib Capsules Sales Share by Application (2021-2032) Figure 49. Europe Selpercatinib Capsules Revenue Share by Country (2021-2032) Figure 50. Europe Selpercatinib Capsules Sales Share by Country (2021-2032) Figure 51. China Selpercatinib Capsules Revenue Share by Type (2021-2032) Figure 52. China Selpercatinib Capsules Sales Share by Type (2021-2032) Figure 53. China Selpercatinib Capsules Revenue Share by Application (2021-2032) Figure 54. China Selpercatinib Capsules Sales Share by Application (2021-2032) Figure 55. Asia Selpercatinib Capsules Revenue Share by Type (2021-2032) Figure 56. Asia Selpercatinib Capsules Sales Share by Type (2021-2032) Figure 57. Asia Selpercatinib Capsules Revenue Share by Application (2021-2032) Figure 58. Asia Selpercatinib Capsules Sales Share by Application (2021-2032) Figure 59. Asia Selpercatinib Capsules Revenue Share by Country (2021-2032) Figure 60. Asia Selpercatinib Capsules Sales Share by Country (2021-2032) Figure 61. SAMEA Selpercatinib Capsules Revenue Share by Type (2021-2032) Figure 62. SAMEA Selpercatinib Capsules Sales Share by Type (2021-2032) Figure 63. SAMEA Selpercatinib Capsules Revenue Share by Application (2021-2032) Figure 64. SAMEA Selpercatinib Capsules Sales Share by Application (2021-2032) Figure 65. SAMEA Selpercatinib Capsules Revenue Share by Country (2021-2032) Figure 66. SAMEA Selpercatinib Capsules Sales Share by Country (2021-2032) Figure 67. Selpercatinib Capsules Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Selpercatinib Capsules Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg
  • 80mg
Applications
  • Thyroid Carcinoma
  • Non-Small Cell Lung Cancer (NSCLC)
  • Others
Companies covered
  • Innovnent Biologics
  • Eli Lilly

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Selpercatinib Capsules Market by Type
  3. 1.2.1 Global Selpercatinib Capsules Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 40mg
  5. 1.2.3 80mg
  6. 1.3 Selpercatinib Capsules Market by Application
  7. 1.3.1 Global Selpercatinib Capsules Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Thyroid Carcinoma
  9. 1.3.3 Non-Small Cell Lung Cancer (NSCLC)
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Selpercatinib Capsules Market Dynamics
  1. 2.1 Selpercatinib Capsules Industry Trends
  2. 2.2 Selpercatinib Capsules Industry Drivers
  3. 2.3 Selpercatinib Capsules Industry Opportunities and Challenges
  4. 2.4 Selpercatinib Capsules Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Selpercatinib Capsules Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Selpercatinib Capsules Revenue by Region
  3. 3.2.1 Global Selpercatinib Capsules Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Selpercatinib Capsules Revenue by Region (2021-2026)
  5. 3.2.3 Global Selpercatinib Capsules Revenue by Region (2027-2032)
  6. 3.2.4 Global Selpercatinib Capsules Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Selpercatinib Capsules Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Selpercatinib Capsules Sales by Region
  9. 3.4.1 Global Selpercatinib Capsules Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Selpercatinib Capsules Sales by Region (2021-2026)
  11. 3.4.3 Global Selpercatinib Capsules Sales by Region (2027-2032)
  12. 3.4.4 Global Selpercatinib Capsules Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Selpercatinib Capsules Revenue by Manufacturers
  2. 4.1.1 Global Selpercatinib Capsules Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Selpercatinib Capsules Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Selpercatinib Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Selpercatinib Capsules Sales by Manufacturers
  6. 4.2.1 Global Selpercatinib Capsules Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Selpercatinib Capsules Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Selpercatinib Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Selpercatinib Capsules Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Selpercatinib Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Selpercatinib Capsules Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Selpercatinib Capsules Manufacturers, Product Type & Application
  13. 4.7 Global Selpercatinib Capsules Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Selpercatinib Capsules Market CR5 and HHI
  16. 4.8.2 2025 Selpercatinib Capsules Tier 1, Tier 2, and Tier 3
5 Selpercatinib Capsules Market by Type
  1. 5.1 Global Selpercatinib Capsules Revenue by Type
  2. 5.1.1 Global Selpercatinib Capsules Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Selpercatinib Capsules Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Selpercatinib Capsules Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Selpercatinib Capsules Sales by Type
  6. 5.2.1 Global Selpercatinib Capsules Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Selpercatinib Capsules Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Selpercatinib Capsules Sales Market Share by Type (2021-2032)
  9. 5.3 Global Selpercatinib Capsules Price by Type
6 Selpercatinib Capsules Market by Application
  1. 6.1 Global Selpercatinib Capsules Revenue by Application
  2. 6.1.1 Global Selpercatinib Capsules Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Selpercatinib Capsules Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Selpercatinib Capsules Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Selpercatinib Capsules Sales by Application
  6. 6.2.1 Global Selpercatinib Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Selpercatinib Capsules Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Selpercatinib Capsules Sales Market Share by Application (2021-2032)
  9. 6.3 Global Selpercatinib Capsules Price by Application
7 Company Profiles
  1. 7.1 Innovnent Biologics
  2. 7.1.1 Innovnent Biologics Company Information
  3. 7.1.2 Innovnent Biologics Business Overview
  4. 7.1.3 Innovnent Biologics Selpercatinib Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Innovnent Biologics Selpercatinib Capsules Product Portfolio
  6. 7.1.5 Innovnent Biologics Recent Developments
  7. 7.2 Eli Lilly
  8. 7.2.1 Eli Lilly Company Information
  9. 7.2.2 Eli Lilly Business Overview
  10. 7.2.3 Eli Lilly Selpercatinib Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eli Lilly Selpercatinib Capsules Product Portfolio
  12. 7.2.5 Eli Lilly Recent Developments
8 North America
  1. 8.1 North America Selpercatinib Capsules Market Size by Type
  2. 8.1.1 North America Selpercatinib Capsules Revenue by Type (2021-2032)
  3. 8.1.2 North America Selpercatinib Capsules Sales by Type (2021-2032)
  4. 8.1.3 North America Selpercatinib Capsules Price by Type (2021-2032)
  5. 8.2 North America Selpercatinib Capsules Market Size by Application
  6. 8.2.1 North America Selpercatinib Capsules Revenue by Application (2021-2032)
  7. 8.2.2 North America Selpercatinib Capsules Sales by Application (2021-2032)
  8. 8.2.3 North America Selpercatinib Capsules Price by Application (2021-2032)
  9. 8.3 North America Selpercatinib Capsules Market Size by Country
  10. 8.3.1 North America Selpercatinib Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Selpercatinib Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Selpercatinib Capsules Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Selpercatinib Capsules Market Size by Type
  2. 9.1.1 Europe Selpercatinib Capsules Revenue by Type (2021-2032)
  3. 9.1.2 Europe Selpercatinib Capsules Sales by Type (2021-2032)
  4. 9.1.3 Europe Selpercatinib Capsules Price by Type (2021-2032)
  5. 9.2 Europe Selpercatinib Capsules Market Size by Application
  6. 9.2.1 Europe Selpercatinib Capsules Revenue by Application (2021-2032)
  7. 9.2.2 Europe Selpercatinib Capsules Sales by Application (2021-2032)
  8. 9.2.3 Europe Selpercatinib Capsules Price by Application (2021-2032)
  9. 9.3 Europe Selpercatinib Capsules Market Size by Country
  10. 9.3.1 Europe Selpercatinib Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Selpercatinib Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Selpercatinib Capsules Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Selpercatinib Capsules Market Size by Type
  2. 10.1.1 China Selpercatinib Capsules Revenue by Type (2021-2032)
  3. 10.1.2 China Selpercatinib Capsules Sales by Type (2021-2032)
  4. 10.1.3 China Selpercatinib Capsules Price by Type (2021-2032)
  5. 10.2 China Selpercatinib Capsules Market Size by Application
  6. 10.2.1 China Selpercatinib Capsules Revenue by Application (2021-2032)
  7. 10.2.2 China Selpercatinib Capsules Sales by Application (2021-2032)
  8. 10.2.3 China Selpercatinib Capsules Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Selpercatinib Capsules Market Size by Type
  2. 11.1.1 Asia Selpercatinib Capsules Revenue by Type (2021-2032)
  3. 11.1.2 Asia Selpercatinib Capsules Sales by Type (2021-2032)
  4. 11.1.3 Asia Selpercatinib Capsules Price by Type (2021-2032)
  5. 11.2 Asia Selpercatinib Capsules Market Size by Application
  6. 11.2.1 Asia Selpercatinib Capsules Revenue by Application (2021-2032)
  7. 11.2.2 Asia Selpercatinib Capsules Sales by Application (2021-2032)
  8. 11.2.3 Asia Selpercatinib Capsules Price by Application (2021-2032)
  9. 11.3 Asia Selpercatinib Capsules Market Size by Country
  10. 11.3.1 Asia Selpercatinib Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Selpercatinib Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Selpercatinib Capsules Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Selpercatinib Capsules Market Size by Type
  2. 12.1.1 SAMEA Selpercatinib Capsules Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Selpercatinib Capsules Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Selpercatinib Capsules Price by Type (2021-2032)
  5. 12.2 SAMEA Selpercatinib Capsules Market Size by Application
  6. 12.2.1 SAMEA Selpercatinib Capsules Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Selpercatinib Capsules Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Selpercatinib Capsules Price by Application (2021-2032)
  9. 12.3 SAMEA Selpercatinib Capsules Market Size by Country
  10. 12.3.1 SAMEA Selpercatinib Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Selpercatinib Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Selpercatinib Capsules Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Selpercatinib Capsules Value Chain Analysis
  2. 13.1.1 Selpercatinib Capsules Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Selpercatinib Capsules Production Mode & Process
  6. 13.2 Selpercatinib Capsules Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Selpercatinib Capsules Distributors
  9. 13.2.3 Selpercatinib Capsules Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst